Showing 4081-4090 of 8791 results for "".
Antifibrotic Drugs for Combined Procedures
https://crstoday.com/crst-issues/2002-oct/1002_231-html/40097/Currently, MMC and 5-FU are the principal antifibrotic drugs used to increase the success of phacotrabeculectomy.MIGS Stent Devices: What's the Evidence?
https://crstoday.com/topics/comorbidities/migs-stent-devices-whats-the-evidence/43813/Presbyopia- Correcting IOLs
https://crstoday.com/topics/general/presbyopia-correcting-iols/41920/Cataracts, Contrast Sensitivity, and IOLs
https://crstoday.com/topics/general/crst0309_13-php/41691/The importance of preoperatively assessing potential retinal acuity in the premium IOL patient.The Perfectly Sized Capsulorhexis
https://crstoday.com/topics/general/crst0609_08-php/41623/Why we should strive to attain it.IOL Power Calculations
https://crstoday.com/topics/general/crst0709_10-php/41609/Achieving optimal refractive outcomes.Durezol Treats Postoperative Inflammation and Pain
https://crstoday.com/topics/general/crst1108_21-php/41345/This powerful corticosteroid is an effective new option for postsurgical care.Endothelial Replacement Surgery
https://crstoday.com/crst-issues/2005-jan/0105_f7_terry-html/40895/A comparison of deep lamellar endothelial keratoplasty and penetrating keratoplasty.Phacoemulsification of the High-Risk Lens
https://crstoday.com/crst-issues/2004-oct/1004_reviv-html/40479/Confronting the quadruple S: small pupil, super-dense lens, shallow chamber, and shaky zonules.Patient-Reported Outcome Measures
https://crstoday.com/crst-issues/aug-2025/patient-reported-outcome-measures/45535/Rethinking success in cataract surgery.
